We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
State Street
STT
$50.9B
| $14.7M | 0.2% |
261,737
-172,352
| -40% | -$10.7M |
|
|
MGLN
127
DELISTED
Magellan Health Services, Inc.
MGLN
| $14.6M | 0.2% |
196,077
+132,444
| +208% | +$8.9M |
|
|
128
EOG Resources
EOG
$78B
| $14.4M | 0.2% |
154,328
-363,240
| -70% | -$33.8M |
|
129
Silgan Holdings
SLGN
$4.91B
| $14.3M | 0.2% |
468,900
+183,002
| +64% | +$5.46M |
|
130
Raymond James Financial
RJF
$32.5B
| $14.3M | 0.2% |
254,090
+26,496
| +12% | +$1.51M |
|
131
Viavi Solutions
VIAV
$9.75B
| $14.3M | 0.2% |
1,074,595
-16,764
| -2% | -$217K |
|
132
Bunge Global
BG
$23.6B
| $14.3M | 0.2% |
256,076
+8,377
| +3% | +$447K |
|
133
Performance Food Group
PFGC
$17.5B
| $14.2M | 0.2% |
+354,193
| New | +$14.2M |
|
134
Quanta Services
PWR
$93.9B
| $14.1M | 0.2% |
370,080
-16,810
| -4% | -$638K |
|
135
Willis Towers Watson
WTW
$27.9B
| $14.1M | 0.2% |
73,765
+58,985
| +399% | +$10.7M |
|
136
Live Nation Entertainment
LYV
$41.2B
| $14M | 0.19% |
211,746
+138,546
| +189% | +$8.9M |
|
137
Dollar Tree
DLTR
$23.1B
| $14M | 0.19% |
129,970
+84,110
| +183% | +$8.85M |
|
138
First Bancorp
FBP
$4.4B
| $13.6M | 0.19% |
1,234,857
+157,979
| +15% | +$1.7M |
|
139
Axalta
AXTA
$7.01B
| $13.6M | 0.19% |
456,930
+80,100
| +21% | +$2.12M |
|
|
CORE
140
DELISTED
Core Mark Holding Co., Inc.
CORE
| $13.5M | 0.19% |
339,774
+24,750
| +8% | +$930K |
|
141
Teradata
TDC
$2.68B
| $13.3M | 0.18% |
371,311
+91,529
| +33% | +$3.57M |
|
|
SPR
142
DELISTED
Spirit AeroSystems
SPR
| $13.3M | 0.18% |
163,430
+150,380
| +1,152% | +$12.7M |
|
|
CMA
143
DELISTED
Comerica
CMA
| $13.2M | 0.18% |
181,690
-61,048
| -25% | -$4.54M |
|
144
Armstrong World Industries
AWI
$6.86B
| $13.2M | 0.18% |
135,420
+2,360
| +2% | +$211K |
|
145
Huntington Ingalls Industries
HII
$11.3B
| $13M | 0.18% |
57,965
+7,482
| +15% | +$1.6M |
|
146
Veeva Systems
VEEV
$30.3B
| $13M | 0.18% |
+80,185
| New | +$11.7M |
|
147
Cardinal Health
CAH
$53.4B
| $12.9M | 0.18% |
274,954
-280,209
| -50% | -$12.9M |
|
148
Douglas Emmett
DEI
$2.06B
| $12.9M | 0.18% |
323,840
+9,470
| +3% | +$388K |
|
149
Yelp
YELP
$1.38B
| $12.9M | 0.18% |
377,095
+39,230
| +12% | +$1.36M |
|
150
Box
BOX
$4.02B
| $12.8M | 0.18% |
728,180
+190,132
| +35% | +$3.64M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.